Molecular Endocrinology, Vol 9, 292-302, Copyright © 1995 by Endocrine Society

ARTICLES

Amino acid residues in the third alpha-helix of growth hormone involved in growth promoting activity

WY Chen, NY Chen, J Yun, DC Wight, XZ Wang, TE Wagner and JJ Kopchick
Edison Biotechnology Institute, Department of Biological Sciences, Ohio University, Athens 45701, USA.

The third amphiphilic alpha-helix of GH has been found to be an important motif in the biological activities of the molecule. To further characterize this growth-promoting domain, three bovine (b) GH analogs were designed: one contained a scrambled third amphiphilic alpha-helix (SAH); a second contained a scrambled hydrophilic region of the helix (SAP); and a third contained a scrambled hydrophobic region of the helix (SAB). Transgenic mice that expressed these mutated bGH genes were produced. SAH transgenic mice displayed a phenotype identical to nontransgenic littermates. SAB transgenic mice grew slightly larger than nontransgenic littermates but remained smaller than bGH transgenic mice. On the other hand, SAP transgenic mice exhibited a dwarf phenotype. We subsequently generated individual amino acid substitutions in the hydrophilic region of the helix. The results from the growth rates of corresponding transgenic mice demonstrated that most bGH analogs with individual amino acid substitution within the third alpha-helix retained wild type-like growth-promoting activity except those with alterations at positions 115, 119, 122, and 123. Together these residues are predicted to form a cleft in the helix. To further substantiate the importance of the cleft, we deleted Gly 119 (delta 119). This resulting bGH analog was inactive in vivo as well as in in vitro assays. These results indicated that the primary structure of the third alpha-helix is critical for GH's growth-promoting activity and Gly 119 is a crucial amino acid in this region. Three adjacent amino acids, Asp 115, Ala 122, and Leu 123, also contribute to the growth-enhancing ability of the molecule.

This article has been cited by other articles:

				Y. Li, J. R. Knapp, and J. J. Kopchick Enlargement of Interscapular Brown Adipose Tissue in Growth Hormone Antagonist Transgenic and in Growth Hormone Receptor Gene-Disrupted Dwarf Mice Experimental Biology and Medicine, February 1, 2003; 228(2): 207 - 215. [Abstract] [Full Text] [PDF]

				J. D. Veldhuis, M. Bidlingmaier, S. M. Anderson, W. S. Evans, Z. Wu, and C. J. Strasburger Impact of Experimental Blockade of Peripheral Growth Hormone (GH) Receptors on the Kinetics of Endogenous and Exogenous GH Removal in Healthy Women and Men J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5737 - 5745. [Abstract] [Full Text] [PDF]

				P. Sorensen, R. Grochowska, L. Holm, M. Henryon, and P. Lovendahl Polymorphism in the Bovine Growth Hormone Gene AffectsEndocrine Release in Dairy Calves J Dairy Sci, July 1, 2002; 85(7): 1887 - 1893. [Abstract] [Full Text] [PDF]

				G. Zhang, W. Li, L. Holle, N. Chen, and W. Y. Chen A Novel Design of Targeted Endocrine and Cytokine Therapy for Breast Cancer Clin. Cancer Res., April 1, 2002; 8(4): 1196 - 1205. [Abstract] [Full Text] [PDF]

				A. F. Muller, F. W. G. Leebeek, J. A. M. J. L. Janssen, S. W. J. Lamberts, L. Hofland, and A. J. van der Lely Acute Effect of Pegvisomant on Cardiovascular Risk Markers in Healthy Men: Implications for the Pathogenesis of Atherosclerosis in GH Deficiency J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5165 - 5171. [Abstract] [Full Text] [PDF]

				P. J. Trainer, W. M. Drake, L. A. Perry, N. F. Taylor, G. M. Besser, and J. P. Monson Modulation of Cortisol Metabolism by the Growth Hormone Receptor Antagonist Pegvisomant in Patients with Acromegaly J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 2989 - 2992. [Abstract] [Full Text] [PDF]

				Y. Li, B. Kelder, and J. J. Kopchick Identification, Isolation, and Cloning of Growth Hormone (GH)-Inducible Interscapular Brown Adipose Complementary Deoxyribonucleic Acid from GH Antagonist Mice Endocrinology, July 1, 2001; 142(7): 2937 - 2945. [Abstract] [Full Text] [PDF]

				Y. SEGEV, D. LANDAU, R. RASCH, A. FLYVBJERG, and M. PHILLIP Growth Hormone Receptor Antagonism Prevents Early Renal in Nonobese Diabetic Mice J. Am. Soc. Nephrol., November 1, 1999; 10(11): 2374 - 2381. [Abstract] [Full Text]

				W. Y. Chen, P. Ramamoorthy, N.-y. Chen, R. Sticca, and T. E. Wagner A Human Prolactin Antagonist, hPRL-G129R, Inhibits Breast Cancer Cell Proliferation through Induction of Apoptosis Clin. Cancer Res., November 1, 1999; 5(11): 3583 - 3593. [Abstract] [Full Text] [PDF]

				D. Helman, N. R. Staten, J. Grosclaude, N. Daniel, C. Nespoulous, J. Djiane, and A. Gertler Novel Recombinant Analogues of Bovine Placental Lactogen. G133K AND G133R PROVIDE A TOOL TO UNDERSTAND THE DIFFERENCE BETWEEN THE ACTION OF PROLACTIN AND GROWTH HORMONE RECEPTORS J. Biol. Chem., June 26, 1998; 273(26): 16067 - 16074. [Abstract] [Full Text] [PDF]

				V. Goffin, S. Kinet, F. Ferrag, N. Binart, J. A. Martial, and P. A. Kelly Antagonistic Properties of Human Prolactin Analogs That Show Paradoxical Agonistic Activity in the Nb2 Bioassay J. Biol. Chem., July 12, 1996; 271(28): 16573 - 16579. [Abstract] [Full Text] [PDF]